ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,186 | -62.6% | 6,705 | -33.7% | 0.00% | – |
| Q2 2023 | $24,565 | -84.9% | 10,109 | -64.1% | 0.00% | – |
| Q1 2023 | $162,259 | -34.6% | 28,170 | +1.5% | 0.00% | – |
| Q4 2022 | $248,112 | -34.5% | 27,753 | +4.1% | 0.00% | -100.0% |
| Q3 2022 | $379,000 | -4.8% | 26,662 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | +80.9% | 27,280 | +147.5% | 0.00% | – |
| Q1 2022 | $220,000 | +11.7% | 11,022 | -1.9% | 0.00% | – |
| Q4 2021 | $197,000 | +123.9% | 11,240 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -70.4% | 11,240 | -61.0% | 0.00% | – |
| Q2 2021 | $297,000 | – | 28,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |